Assenagon Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Buy |
+39,610
| New | +$122K | ﹤0.01% | 1108 |
|
|
2024
Q1 | – | Sell |
-817,574
| Closed | -$2.04M | – | 1315 |
|
|
2023
Q4 | $2.04M | Hold |
817,574
| – | – | 0.01% | 887 |
|
|
2023
Q3 | $1.66M | Hold |
817,574
| – | – | 0.01% | 895 |
|
|
2023
Q2 | $1.88M | Hold |
817,574
| – | – | 0.01% | 779 |
|
|
2023
Q1 | $2.48M | Hold |
817,574
| – | – | 0.01% | 740 |
|
|
2022
Q4 | $1.91M | Sell |
817,574
-1,077,587
| -57% | -$2.51M | 0.01% | 797 |
|
|
2022
Q3 | $3.62M | Sell |
1,895,161
-226,245
| -11% | -$432K | 0.01% | 533 |
|
|
2022
Q2 | $5.75M | Hold |
2,121,406
| – | – | 0.02% | 481 |
|
|
2022
Q1 | $6.32M | Buy |
2,121,406
+2,034,737
| +2,348% | +$6.06M | 0.02% | 451 |
|
|
2021
Q4 | $337K | Buy |
+86,669
| New | +$337K | ﹤0.01% | 1230 |
|
|
2021
Q3 | – | Sell |
-17,851
| Closed | -$54K | – | 1230 |
|
|
2021
Q2 | $54K | Buy |
+17,851
| New | +$54K | ﹤0.01% | 1135 |
|
|
2020
Q4 | – | Sell |
-44,362
| Closed | -$139K | – | 939 |
|
|
2020
Q3 | $139K | Buy |
+44,362
| New | +$139K | ﹤0.01% | 1046 |
|
|
2019
Q3 | – | Sell |
-119,800
| Closed | -$249K | – | 773 |
|
|
2019
Q2 | $249K | Buy |
+119,800
| New | +$249K | ﹤0.01% | 894 |
|